RenovoRx, Inc.
RNXT- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001574094
No open-market purchases or sales by RenovoRx, Inc. insiders were filed in the last 90 days; 28 institutions reported holding it in 13F filings for Q2 2026, worth $9.00M in total; no superinvestor holds it.
13F holders, Q4 2021
Institutional positions in RenovoRx, Inc. as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 9
- +2 vs. Q3 2021
- Shares held
- 104.4K
- −53.7K (−34.0%) vs. Q3 2021
- Total value
- $506.0K
- −$451.0K (−47.1%) vs. Q3 2021
- New holders
- 6
- 0 more added
- Sold out
- 4
- 2 more reduced
1 institution that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting RNXT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 28 | $9.00M |
| Q1 2026 | 31 | $8.58M |
| Q4 2025 | 33 | $6.83M |
| Q3 2025 | 31 | $9.04M |
| Q2 2025 | 25 | $11.6M |
| Q1 2025 | 27 | $9.98M |
| Q4 2024 | 18 | $1.31M |
| Q3 2024 | 13 | $2.00M |
| Q2 2024 | 17 | $1.01M |
| Q1 2024 | 10 | $441.6K |
| Q4 2023 | 12 | $758.1K |
| Q3 2023 | 14 | $473.5K |
| Q2 2023 | 9 | $552.2K |
| Q1 2023 | 12 | $9.64M |
| Q4 2022 | 11 | $2.75M |
| Q3 2022 | 13 | $2.49M |
| Q2 2022 | 11 | $2.35M |
| Q1 2022 | 12 | $482.0K |
| Q4 2021 | 9 | $506.0K |
| Q3 2021 | 8 | $1.02M |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2021
Shares, value and share of portfolio for each institution holding RenovoRx, Inc.; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Board of Trustees of The Leland Stanford Junior University | 60,863 | $295.0K | 0.02% | 00.0% | Unchanged |
| Cambridge Investment Research Advisors, Inc. | 14,400 | $70.0K | 0.00% | −26,450−64.7% | Reduced |
| Virtu Financial LLC | 13,208 | $64.0K | 0.01% | +13,208 | New |
| Verition Fund Management LLC | 10,283 | $50.0K | 0.00% | +10,283 | New |
| UBS Group AG | 4,512 | $22.0K | 0.00% | +4,512 | New |
| Tower Research Capital LLC (TRC) | 891 | $4.00K | 0.00% | −4,821−84.4% | Reduced |
| Carmichael Hill & Associates, Inc. | 200 | $1.00K | 0.00% | +200 | New |
| Wells Fargo & Company | 11 | $0 | 0.00% | +11 | New |
| Sterling Investment Advisors, Ltd. | 16 | $0 | 0.00% | +16 | New |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −20,569−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −17,944−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −12,010−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| Harbor Financial Services, LLC | – | – | – | – | Not filed |